Header Logo

Connection

MARY ESTES to Gastroenteritis

Back to Details
This is a "connection" page, showing publications MARY ESTES has written about Gastroenteritis.
MARY ESTES
Connection Strength
9.901
Gastroenteritis
  1. Norovirus replication, host interactions and vaccine advances. Nat Rev Microbiol. 2025 Jun; 23(6):385-401.
    View in: PubMed
    Score: 0.768
  2. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity. Antimicrob Agents Chemother. 2023 10 18; 67(10):e0063623.
    View in: PubMed
    Score: 0.702
  3. Antiviral Activity of Olanexidine-Containing Hand Rub against Human Noroviruses. mBio. 2022 04 26; 13(2):e0284821.
    View in: PubMed
    Score: 0.631
  4. Human noroviruses: recent advances in a 50-year history. Curr Opin Infect Dis. 2018 10; 31(5):422-432.
    View in: PubMed
    Score: 0.496
  5. Viral gastroenteritis. Lancet. 2018 07 14; 392(10142):175-186.
    View in: PubMed
    Score: 0.487
  6. Replication of human noroviruses in stem cell-derived human enteroids. Science. 2016 09 23; 353(6306):1387-1393.
    View in: PubMed
    Score: 0.429
  7. Structural basis of glycan interaction in gastroenteric viral pathogens. Curr Opin Virol. 2014 Aug; 7:119-27.
    View in: PubMed
    Score: 0.371
  8. Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol. 2014 Jan; 30(1):25-33.
    View in: PubMed
    Score: 0.357
  9. A time-resolved immunoassay to measure serum antibodies to the rotavirus VP6 capsid protein. J Virol Methods. 2013 Apr; 189(1):228-31.
    View in: PubMed
    Score: 0.331
  10. Norovirus vaccine development: next steps. Expert Rev Vaccines. 2012 Sep; 11(9):1023-5.
    View in: PubMed
    Score: 0.326
  11. Norovirus gastroenteritis. N Engl J Med. 2009 Oct 29; 361(18):1776-85.
    View in: PubMed
    Score: 0.267
  12. Rotaviruses: from pathogenesis to vaccination. Gastroenterology. 2009 May; 136(6):1939-51.
    View in: PubMed
    Score: 0.259
  13. Rotavirus vaccines and pathogenesis: 2008. Curr Opin Gastroenterol. 2009 Jan; 25(1):36-43.
    View in: PubMed
    Score: 0.253
  14. Noroviruses everywhere: has something changed? Curr Opin Infect Dis. 2006 Oct; 19(5):467-74.
    View in: PubMed
    Score: 0.216
  15. Insights into human norovirus cultivation in human intestinal enteroids. mSphere. 2024 Nov 21; 9(11):e0044824.
    View in: PubMed
    Score: 0.189
  16. Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibition. J Virol. 2024 Jul 23; 98(7):e0202023.
    View in: PubMed
    Score: 0.184
  17. Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol. 2004 Jun; 12(6):279-87.
    View in: PubMed
    Score: 0.184
  18. A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies. J Infect Dis. 2024 May 15; 229(5):1402-1407.
    View in: PubMed
    Score: 0.183
  19. Rotavirus-mediated DGAT1 degradation: A pathophysiological mechanism of viral-induced malabsorptive diarrhea. Proc Natl Acad Sci U S A. 2023 Dec 19; 120(51):e2302161120.
    View in: PubMed
    Score: 0.178
  20. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis. 2002 May 01; 185(9):1335-7.
    View in: PubMed
    Score: 0.159
  21. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J Virol. 2001 Oct; 75(20):9713-22.
    View in: PubMed
    Score: 0.153
  22. Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin Microbiol Rev. 2001 Jan; 14(1):15-37.
    View in: PubMed
    Score: 0.145
  23. Structural studies on gastroenteritis viruses. Novartis Found Symp. 2001; 238:26-37; discussion 37-46.
    View in: PubMed
    Score: 0.145
  24. Pathogenesis of rotavirus gastroenteritis. Novartis Found Symp. 2001; 238:82-96; discussion 96-100.
    View in: PubMed
    Score: 0.145
  25. Antiviral targets of human noroviruses. Curr Opin Virol. 2016 06; 18:117-25.
    View in: PubMed
    Score: 0.106
  26. Norovirus Gastroenteritis in a Birth Cohort in Southern India. PLoS One. 2016; 11(6):e0157007.
    View in: PubMed
    Score: 0.106
  27. Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go? PLoS Pathog. 2016 04; 12(4):e1005334.
    View in: PubMed
    Score: 0.105
  28. Structure of Norwalk virus. Arch Virol Suppl. 1996; 12:237-42.
    View in: PubMed
    Score: 0.103
  29. Mucosal and Cellular Immune Responses to Norwalk Virus. J Infect Dis. 2015 Aug 01; 212(3):397-405.
    View in: PubMed
    Score: 0.096
  30. Characterization of SRSVs using RT-PCR and a new antigen ELISA. Arch Virol. 1995; 140(2):363-74.
    View in: PubMed
    Score: 0.096
  31. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis. 2015 Mar 15; 211(6):870-8.
    View in: PubMed
    Score: 0.094
  32. Reply to Kirby et al. J Infect Dis. 2015 Jan 01; 211(1):167.
    View in: PubMed
    Score: 0.093
  33. Development of a Gaussia luciferase-based human norovirus protease reporter system: cell type-specific profile of Norwalk virus protease precursors and evaluation of inhibitors. J Virol. 2014 Sep; 88(18):10312-26.
    View in: PubMed
    Score: 0.093
  34. Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis. 1994 Jul; 170(1):34-43.
    View in: PubMed
    Score: 0.092
  35. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis. 2014 Apr 01; 209(7):1016-22.
    View in: PubMed
    Score: 0.089
  36. Identification and characterization of a peptide affinity reagent for detection of noroviruses in clinical samples. J Clin Microbiol. 2013 Jun; 51(6):1803-8.
    View in: PubMed
    Score: 0.085
  37. Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis. 2013 Mar; 19(3):431-8.
    View in: PubMed
    Score: 0.084
  38. Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol. 2012 Feb; 19(2):284-7.
    View in: PubMed
    Score: 0.078
  39. Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis. 2010 Oct 15; 202(8):1212-8.
    View in: PubMed
    Score: 0.071
  40. Impact of rotavirus infection at a large pediatric hospital. J Infect Dis. 1990 Sep; 162(3):598-604.
    View in: PubMed
    Score: 0.071
  41. Norwalk virus shedding after experimental human infection. Emerg Infect Dis. 2008 Oct; 14(10):1553-7.
    View in: PubMed
    Score: 0.062
  42. Electron microscopy procedure influences detection of rotaviruses. J Clin Microbiol. 1987 Oct; 25(10):1902-6.
    View in: PubMed
    Score: 0.058
  43. Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol J. 2006 Jul; 4(4):419-32.
    View in: PubMed
    Score: 0.053
  44. Norwalk virus-specific binding to oyster digestive tissues. Emerg Infect Dis. 2006 Jun; 12(6):931-6.
    View in: PubMed
    Score: 0.053
  45. The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am. 2006 Jun; 35(2):275-90, viii.
    View in: PubMed
    Score: 0.053
  46. Oral immunization with a shiga toxin B subunit: rotavirus NSP4(90) fusion protein protects mice against gastroenteritis. Vaccine. 2005 Oct 25; 23(44):5168-76.
    View in: PubMed
    Score: 0.051
  47. Conformational flexibility is a critical factor in designing broad-spectrum human norovirus protease inhibitors. J Virol. 2025 Feb 25; 99(2):e0175724.
    View in: PubMed
    Score: 0.048
  48. 2'-Fucosyllactose inhibits human norovirus replication in human intestinal enteroids. J Virol. 2025 Feb 25; 99(2):e0093824.
    View in: PubMed
    Score: 0.048
  49. Laboratory efforts to cultivate noroviruses. J Gen Virol. 2004 Jan; 85(Pt 1):79-87.
    View in: PubMed
    Score: 0.045
  50. Human Sapovirus Replication in Human Intestinal Enteroids. J Virol. 2023 04 27; 97(4):e0038323.
    View in: PubMed
    Score: 0.042
  51. Expression and self-assembly of Grimsby virus: antigenic distinction from Norwalk and Mexico viruses. Clin Diagn Lab Immunol. 1999 Jan; 6(1):142-5.
    View in: PubMed
    Score: 0.032
  52. B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. Clin Vaccine Immunol. 2017 May; 24(5).
    View in: PubMed
    Score: 0.028
  53. Detection and analysis of a small round-structured virus strain in oysters implicated in an outbreak of acute gastroenteritis. Appl Environ Microbiol. 1996 Nov; 62(11):4268-72.
    View in: PubMed
    Score: 0.027
  54. Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding. PLoS Pathog. 2016 06; 12(6):e1005719.
    View in: PubMed
    Score: 0.027
  55. Recombinant Norwalk virus-like particles as an oral vaccine. Arch Virol Suppl. 1996; 12:243-9.
    View in: PubMed
    Score: 0.026
  56. Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus. Nat Commun. 2015 Sep 30; 6:8346.
    View in: PubMed
    Score: 0.025
  57. Detection of Norwalk virus and hepatitis A virus in shellfish tissues with the PCR. Appl Environ Microbiol. 1995 Aug; 61(8):3014-8.
    View in: PubMed
    Score: 0.025
  58. Sensitive detection of norovirus using phage nanoparticle reporters in lateral-flow assay. PLoS One. 2015; 10(5):e0126571.
    View in: PubMed
    Score: 0.025
  59. Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med. 2014 Jan-Feb; 21(1):6-11.
    View in: PubMed
    Score: 0.022
  60. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med. 2011 Dec 08; 365(23):2178-87.
    View in: PubMed
    Score: 0.019
  61. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med. 2011 Jul 28; 365(4):337-46.
    View in: PubMed
    Score: 0.019
  62. Norwalk virus genome cloning and characterization. Science. 1990 Dec 14; 250(4987):1580-3.
    View in: PubMed
    Score: 0.018
  63. Serotype variation of human group A rotaviruses in two regions of the USA. J Infect Dis. 1990 Sep; 162(3):605-14.
    View in: PubMed
    Score: 0.018
  64. Asymptomatic human calicivirus infection in a day care center. Pediatr Infect Dis J. 1990 Mar; 9(3):190-6.
    View in: PubMed
    Score: 0.017
  65. Molecular biology and immunology of rotavirus infections. Immunol Invest. 1989 Jan-May; 18(1-4):571-81.
    View in: PubMed
    Score: 0.016
  66. Development of a reverse transcription-PCR-DNA enzyme immunoassay for detection of "Norwalk-like" viruses and hepatitis A virus in stool and shellfish. Appl Environ Microbiol. 2001 Feb; 67(2):742-9.
    View in: PubMed
    Score: 0.009
  67. Development of an immunomagnetic capture reverse transcription-PCR assay for the detection of Norwalk virus. J Virol Methods. 2000 Oct; 90(1):69-78.
    View in: PubMed
    Score: 0.009
  68. Development of methods to detect "Norwalk-like viruses" (NLVs) and hepatitis A virus in delicatessen foods: application to a food-borne NLV outbreak. Appl Environ Microbiol. 2000 Jan; 66(1):213-8.
    View in: PubMed
    Score: 0.008
  69. Detection of human calicivirus antigen and antibody by enzyme-linked immunosorbent assays. J Clin Microbiol. 1988 Oct; 26(10):2001-5.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.